# Beeline Holdings, Inc.: financial statements, quarterly

BLNE · Nasdaq · CIK 1534708 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/blne.md) · [Financials](/companies/blne/financials.md) · [Filings](/companies/blne/filings.md) · [Insiders](/companies/blne/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/blne/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [806](/filings/0001493152-24-046343.md) | [7,560 d](/filings/0001493152-24-012410.md) | [2,411](/filings/0001493152-24-018888.md) | [2,952](/filings/0001493152-24-032215.md) | [760](/filings/0001493152-24-046343.md) | [(867) d](/filings/0001493152-26-014135.md) | [1,247](/filings/0001493152-26-023753.md) | [1,676](/filings/0001493152-26-038338.md) | [2,344](/filings/0001493152-25-023462.md) | [2,359 d](/filings/0001493152-26-014135.md) | [2,696](/filings/0001493152-26-023753.md) | [2,625](/filings/0001493152-26-038338.md) |
| Cost of revenue | $k | [638](/filings/0001493152-24-046343.md) | [7,498 d](/filings/0001493152-24-012410.md) | [2,225](/filings/0001493152-24-018888.md) | [2,799](/filings/0001493152-24-032215.md) | [560](/filings/0001493152-24-046343.md) | not reported | not reported | not reported | not reported | not reported | [50.0](/filings/0001493152-26-023753.md) | not reported |
| Gross profit | $k | [168](/filings/0001493152-24-046343.md) | [62.0 d](/filings/0001493152-24-012410.md) | [186](/filings/0001493152-24-018888.md) | [153](/filings/0001493152-24-032215.md) | [200](/filings/0001493152-24-046343.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $k | [(307)](/filings/0001493152-24-046343.md) | [(953) d](/filings/0001641172-25-004793.md) | [(461)](/filings/0001641172-25-011724.md) | [(350)](/filings/0001641172-25-024044.md) | [(435)](/filings/0001493152-25-023462.md) | [(4,035) d](/filings/0001493152-26-014135.md) | [(4,757)](/filings/0001493152-26-023753.md) | [(3,896)](/filings/0001493152-26-038338.md) | [(2,833)](/filings/0001493152-25-023462.md) | [(8,061) d](/filings/0001493152-26-014135.md) | [(5,167)](/filings/0001493152-26-023753.md) | [(4,490)](/filings/0001493152-26-038338.md) |
| Interest expense | $k | [207](/filings/0001493152-23-041095.md) | [246 d](/filings/0001493152-24-012410.md) | [248](/filings/0001493152-24-018888.md) | [308](/filings/0001641172-25-024044.md) | [409](/filings/0001493152-25-023462.md) | [1,271 d](/filings/0001493152-26-014135.md) | [1,889](/filings/0001493152-26-023753.md) | [388](/filings/0001493152-26-038338.md) | [69.0](/filings/0001493152-25-023462.md) | [(79.0) d](/filings/0001493152-26-014135.md) | not reported | not reported |
| Net income | $k | [(2,156)](/filings/0001493152-24-046343.md) | [(2,138) d](/filings/0001641172-25-004793.md) | [(1,293)](/filings/0001641172-25-011724.md) | [(1,488)](/filings/0001641172-25-024044.md) | [(1,359)](/filings/0001493152-25-023462.md) | [(7,193) d](/filings/0001493152-26-014135.md) | [(6,822)](/filings/0001493152-26-023753.md) | [(4,075)](/filings/0001493152-26-038338.md) | [(3,918)](/filings/0001493152-25-023462.md) | [(8,352) d](/filings/0001493152-26-014135.md) | [(5,278)](/filings/0001493152-26-023753.md) | [(4,034)](/filings/0001493152-26-038338.md) |
| Diluted EPS | $ per share | [(2.00)](/filings/0001493152-23-041095.md) | not reported | [(0.78)](/filings/0001493152-24-018888.md) | [(8.74)](/filings/0001641172-25-024044.md) | [(6.60)](/filings/0001493152-25-023462.md) | not reported | [(6.14)](/filings/0001493152-26-023753.md) | [(0.64)](/filings/0001493152-26-038338.md) | [(0.20)](/filings/0001493152-25-023462.md) | not reported | [(0.18)](/filings/0001493152-26-023753.md) | [(0.13)](/filings/0001493152-26-038338.md) |
| Basic EPS | $ per share | [(2.00)](/filings/0001493152-24-046343.md) | not reported | [(7.80)](/filings/0001641172-25-011724.md) | [(8.74)](/filings/0001641172-25-024044.md) | [(6.60)](/filings/0001493152-25-023462.md) | not reported | [(6.14)](/filings/0001493152-26-023753.md) | [(0.64)](/filings/0001493152-26-038338.md) | [(0.20)](/filings/0001493152-25-023462.md) | not reported | [(0.18)](/filings/0001493152-26-023753.md) | [(0.13)](/filings/0001493152-26-038338.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold, us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.4](/filings/0001493152-23-041095.md) | [0.3](/filings/0001641172-25-004793.md) | [0.1](/filings/0001641172-25-011724.md) | [0.4](/filings/0001493152-24-032215.md) | [0.3](/filings/0001493152-24-046343.md) | [0.1](/filings/0001493152-26-014135.md) | [1.4](/filings/0001493152-26-023753.md) | [6.3](/filings/0001493152-26-038338.md) | [1.3](/filings/0001493152-25-023462.md) | [3.1](/filings/0001493152-26-038338.md) | [1.9](/filings/0001493152-26-023753.md) | [1.4](/filings/0001493152-26-038338.md) |
| Current assets | $m | [5.7](/filings/0001493152-23-041095.md) | [4.5](/filings/0001641172-25-004793.md) | [4.7](/filings/0001493152-24-018888.md) | [4.9](/filings/0001493152-24-032215.md) | [5.0](/filings/0001493152-24-046343.md) | [10.0](/filings/0001493152-26-014135.md) | [8.7](/filings/0001641172-25-011724.md) | [14.7](/filings/0001641172-25-024044.md) | [10.9](/filings/0001493152-25-023462.md) | [19.4](/filings/0001493152-26-038338.md) | [20.4](/filings/0001493152-26-023753.md) | [13.2](/filings/0001493152-26-038338.md) |
| Total assets | $m | [18.8](/filings/0001493152-23-041095.md) | [17.5](/filings/0001641172-25-004793.md) | [17.0](/filings/0001493152-24-018888.md) | [16.6](/filings/0001493152-24-032215.md) | [16.2](/filings/0001493152-24-046343.md) | [66.5](/filings/0001493152-26-014135.md) | [63.8](/filings/0001641172-25-011724.md) | [68.6](/filings/0001641172-25-024044.md) | [63.2](/filings/0001493152-25-023462.md) | [70.2](/filings/0001493152-26-038338.md) | [70.3](/filings/0001493152-26-023753.md) | [62.9](/filings/0001493152-26-038338.md) |
| Current liabilities | $m | [4.0](/filings/0001493152-23-041095.md) | [4.2](/filings/0001641172-25-004793.md) | [15.9](/filings/0001493152-24-018888.md) | [17.2](/filings/0001493152-24-032215.md) | [17.6](/filings/0001493152-24-046343.md) | [16.2](/filings/0001493152-26-014135.md) | [14.6](/filings/0001641172-25-011724.md) | [12.1](/filings/0001641172-25-024044.md) | [10.5](/filings/0001493152-25-023462.md) | [16.3](/filings/0001493152-26-038338.md) | [19.2](/filings/0001493152-26-023753.md) | [12.4](/filings/0001493152-26-038338.md) |
| Total liabilities | $m | [16.1](/filings/0001493152-23-041095.md) | [16.6](/filings/0001641172-25-004793.md) | [17.5](/filings/0001493152-24-018888.md) | [18.5](/filings/0001493152-24-032215.md) | [18.7](/filings/0001493152-24-046343.md) | [17.5](/filings/0001493152-26-014135.md) | [15.7](/filings/0001641172-25-011724.md) | [13.0](/filings/0001641172-25-024044.md) | [11.4](/filings/0001493152-25-023462.md) | [16.6](/filings/0001493152-26-038338.md) | [19.4](/filings/0001493152-26-023753.md) | [12.4](/filings/0001493152-26-038338.md) |
| Long-term debt | $m | [8.0](/filings/0001493152-23-041095.md) | [8.0](/filings/0001493152-24-012410.md) | [8.1](/filings/0001493152-24-018888.md) | [8.1](/filings/0001493152-24-032215.md) | [8.2](/filings/0001493152-24-046343.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [2.7](/filings/0001493152-24-046343.md) | [0.9](/filings/0001641172-25-004793.md) | [(0.5)](/filings/0001493152-24-046343.md) | [(1.9)](/filings/0001493152-24-046343.md) | [(2.5)](/filings/0001493152-24-046343.md) | [47.9](/filings/0001493152-26-014135.md) | [47.1](/filings/0001641172-25-011724.md) | [54.6](/filings/0001641172-25-024044.md) | [51.7](/filings/0001493152-25-023462.md) | [53.6](/filings/0001493152-26-038338.md) | [50.9](/filings/0001493152-26-023753.md) | [50.5](/filings/0001493152-26-038338.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(1.1) d](/filings/0001493152-24-046343.md) | [(0.1) d](/filings/0001641172-25-004793.md) | [(0.1)](/filings/0001641172-25-011724.md) | [(0.9) d](/filings/0001641172-25-024044.md) | [(0.7) d](/filings/0001493152-25-023462.md) | [(1.6) d](/filings/0001493152-26-014135.md) | [(1.3)](/filings/0001493152-26-023753.md) | [(4.3) d](/filings/0001493152-26-038338.md) | [(5.8) d](/filings/0001493152-25-023462.md) | [(10.0) d](/filings/0001493152-26-014135.md) | [(3.6)](/filings/0001493152-26-023753.md) | [2.2 d](/filings/0001493152-26-038338.md) |
| Capital expenditure | $m | [(0.0) d](/filings/0001493152-24-046343.md) | [0.0 d](/filings/0001641172-25-004793.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [15.3](/filings/0001493152-22-022079.md) | [0.0](/filings/0001493152-23-041095.md) | [0.8](/filings/0001493152-24-018888.md) | [0.0](/filings/0001493152-23-041095.md) | [1.7](/filings/0001493152-24-018888.md) | [0.2](/filings/0001641172-25-024044.md) | [0.2](/filings/0001493152-25-023462.md) | [1.9](/filings/0001493152-26-023753.md) | [9.8](/filings/0001493152-26-038338.md) | [19.3](/filings/0001493152-25-023462.md) | [29.4](/filings/0001493152-26-023753.md) | [31.4](/filings/0001493152-26-038338.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 32,928,148 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-038338.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.